-
1
-
-
15644382459
-
Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors. Northern New England Cardiovascular Disease Study Group
-
L.J. Dacey, J.J. Munoz, Y.R. Baribeau, E.R. Johnson, S.J. Lahey, B.J. Leavitt, R.D. Quinn, W.C. Nugent, J.D. Birkmeyer, and G.T. O'Connor Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group Arch Surg 133 1998 442 447
-
(1998)
Arch Surg
, vol.133
, pp. 442-447
-
-
Dacey, L.J.1
Munoz, J.J.2
Baribeau, Y.R.3
Johnson, E.R.4
Lahey, S.J.5
Leavitt, B.J.6
Quinn, R.D.7
Nugent, W.C.8
Birkmeyer, J.D.9
O'Connor, G.T.10
-
2
-
-
0035163406
-
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
-
G.J. Despotis, M.S. Avidan, and C.W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1821 S1831
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Despotis, G.J.1
Avidan, M.S.2
Hogue Jr., C.W.3
-
3
-
-
4444229924
-
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial
-
K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, B.J. Gersh, and S. Yusuf Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
-
(2004)
Circulation
, vol.110
, pp. 1202-1208
-
-
Fox, K.A.1
Mehta, S.R.2
Peters, R.3
Zhao, F.4
Lakkis, N.5
Gersh, B.J.6
Yusuf, S.7
-
4
-
-
2942598308
-
Impact of clopidogrel in coronary artery bypass grafting
-
L. Englberger, B. Faeh, P.A. Berdat, F. Eberli, B. Meier, and T. Carrel Impact of clopidogrel in coronary artery bypass grafting Eur J Cardiothorac Surg 26 2004 96 101
-
(2004)
Eur J Cardiothorac Surg
, vol.26
, pp. 96-101
-
-
Englberger, L.1
Faeh, B.2
Berdat, P.A.3
Eberli, F.4
Meier, B.5
Carrel, T.6
-
5
-
-
0036363842
-
Potential role for rFVIIa in transfusion medicine
-
U. Hedner, and E. Erhardtsen Potential role for rFVIIa in transfusion medicine Transfusion 42 2002 114 124
-
(2002)
Transfusion
, vol.42
, pp. 114-124
-
-
Hedner, U.1
Erhardtsen, E.2
-
6
-
-
0031788228
-
Recombinant activated factor VII as a universal haemostatic agent
-
U. Hedner Recombinant activated factor VII as a universal haemostatic agent Blood Coagul Fibrinolysis 9 1998 S147 S152
-
(1998)
Blood Coagul Fibrinolysis
, vol.9
-
-
Hedner, U.1
-
7
-
-
0033610715
-
Treatment of traumatic bleeding with recombinant factor VIIa
-
G. Kenet, R. Walden, A. Eldad, and U. Martinowitz Treatment of traumatic bleeding with recombinant factor VIIa Lancet 354 1999 1879
-
(1999)
Lancet
, vol.354
, pp. 1879
-
-
Kenet, G.1
Walden, R.2
Eldad, A.3
Martinowitz, U.4
-
8
-
-
0034045208
-
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
-
M. Al Douri, T. Shafi, D. Al Khudairi, E. Al Bokhari, L. Black, N. Akinwale, M. Osman Musa, A. Al Homaidhi, M. Al Fagih, and R. Borum Andreasen Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery Blood Coagul Fibrinolysis 11 2000 S121 S127
-
(2000)
Blood Coagul Fibrinolysis
, vol.11
-
-
Al Douri, M.1
Shafi, T.2
Al Khudairi, D.3
Al Bokhari, E.4
Black, L.5
Akinwale, N.6
Osman Musa, M.7
Al Homaidhi, A.8
Al Fagih, M.9
Borum Andreasen, R.10
-
9
-
-
0034914327
-
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
-
H.G. Hendriks, J.M. van der Maaten, J. de Wolf, T.W. Waterbolk, M.J. Slooff, and J. van der Meer An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII Anesth Analg 93 2001 287 289
-
(2001)
Anesth Analg
, vol.93
, pp. 287-289
-
-
Hendriks, H.G.1
Van Der Maaten, J.M.2
De Wolf, J.3
Waterbolk, T.W.4
Slooff, M.J.5
Van Der Meer, J.6
-
10
-
-
0036711777
-
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
-
M. Kastrup, C. von Heymann, H. Hotz, W.F. Konertz, S. Ziemer, W.J. Kox, and C. Spies Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta Ann Thorac Surg 74 2002 910 912
-
(2002)
Ann Thorac Surg
, vol.74
, pp. 910-912
-
-
Kastrup, M.1
Von Heymann, C.2
Hotz, H.3
Konertz, W.F.4
Ziemer, S.5
Kox, W.J.6
Spies, C.7
-
11
-
-
0042925371
-
Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass
-
V.N. Naik, C.D. Mazer, D.A. Latter, J.M. Teitel, and G.M. Hare Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass Can J Anaesth 50 2003 599 602
-
(2003)
Can J Anaesth
, vol.50
, pp. 599-602
-
-
Naik, V.N.1
Mazer, C.D.2
Latter, D.A.3
Teitel, J.M.4
Hare, G.M.5
-
12
-
-
0036795428
-
Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery
-
C. von Heymann, H. Hotz, W. Konertz, W.J. Kox, and C. Spies Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 16 2002 615 616
-
(2002)
J Cardiothorac Vasc Anesth
, vol.16
, pp. 615-616
-
-
Von Heymann, C.1
Hotz, H.2
Konertz, W.3
Kox, W.J.4
Spies, C.5
-
13
-
-
19444374002
-
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
-
A. Aggarwal, V. Malkovska, J.P. Catlett, and K. Alcorn Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage Thromb J 2 2004 9
-
(2004)
Thromb J
, vol.2
, pp. 9
-
-
Aggarwal, A.1
Malkovska, V.2
Catlett, J.P.3
Alcorn, K.4
-
14
-
-
0028933865
-
Hemostatic complications of cardiopulmonary bypass
-
R.W. Colman Hemostatic complications of cardiopulmonary bypass Am J Hematol 48 1995 267 272
-
(1995)
Am J Hematol
, vol.48
, pp. 267-272
-
-
Colman, R.W.1
-
15
-
-
0038375322
-
The management of perioperative bleeding
-
M.B. Koh, and B.J. Hunt The management of perioperative bleeding Blood Rev 17 2003 179 185
-
(2003)
Blood Rev
, vol.17
, pp. 179-185
-
-
Koh, M.B.1
Hunt, B.J.2
-
16
-
-
3242803508
-
Reexploration for bleeding after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay
-
S. Karthik, A.D. Grayson, E.E. McCarron, D.M. Pullan, and M.J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann Thorac Surg 78 2004 527 534
-
(2004)
Ann Thorac Surg
, vol.78
, pp. 527-534
-
-
Karthik, S.1
Grayson, A.D.2
McCarron, E.E.3
Pullan, D.M.4
Desmond, M.J.5
-
17
-
-
0242267415
-
Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review
-
M. Grounds Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review Blood Rev 17 2003 S11 S21
-
(2003)
Blood Rev
, vol.17
-
-
Grounds, M.1
-
18
-
-
3442877919
-
Recombinant activated factor VII (NovoSeven): Addition to replacement therapy in acute, uncontrolled and life-threatening bleeding
-
A. Mayo, M. Misgav, Y. Kluger, R. Geenberg, D. Pauzner, J. Klausner, and O. Ben-Tal Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding Vox Sang 87 2004 34 40
-
(2004)
Vox Sang
, vol.87
, pp. 34-40
-
-
Mayo, A.1
Misgav, M.2
Kluger, Y.3
Geenberg, R.4
Pauzner, D.5
Klausner, J.6
Ben-Tal, O.7
-
19
-
-
0348163468
-
The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients
-
Z.H. Meng, A.S. Wolberg, D.M. Monroe 3rd, and M. Hoffman The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 55 2003 886 891
-
(2003)
J Trauma
, vol.55
, pp. 886-891
-
-
Meng, Z.H.1
Wolberg, A.S.2
Monroe III, D.M.3
Hoffman, M.4
-
20
-
-
0036241743
-
Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
-
W. Dietrich, and M. Spannagl Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery Anesth Analg 94 2002 1369 1370
-
(2002)
Anesth Analg
, vol.94
, pp. 1369-1370
-
-
Dietrich, W.1
Spannagl, M.2
-
21
-
-
1942532344
-
Recombinant activated factor VII in paediatric cardiac surgery
-
J.R. Egan, A. Lammi, D.N. Schell, J. Gillis, and G.R. Nunn Recombinant activated factor VII in paediatric cardiac surgery Intensive Care Med 30 2004 682 685
-
(2004)
Intensive Care Med
, vol.30
, pp. 682-685
-
-
Egan, J.R.1
Lammi, A.2
Schell, D.N.3
Gillis, J.4
Nunn, G.R.5
-
22
-
-
3042651670
-
Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin
-
D.R. McIlroy, and A.J. Silvers Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin Anesth Analg 99 2004 27 30
-
(2004)
Anesth Analg
, vol.99
, pp. 27-30
-
-
McIlroy, D.R.1
Silvers, A.J.2
-
23
-
-
5144222624
-
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial
-
J. Bosch, D. Thabut, F. Bendtsen, G. D'Amico, A. Albillos, J. Gonzalez Abraldes, S. Fabricius, E. Erhardtsen, R. de Franchis, and European Study Group on rFVIIa in UGI Haemorrhage Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial Gastroenterology 127 2004 1123 1130
-
(2004)
Gastroenterology
, vol.127
, pp. 1123-1130
-
-
Bosch, J.1
Thabut, D.2
Bendtsen, F.3
D'Amico, G.4
Albillos, A.5
Gonzalez Abraldes, J.6
Fabricius, S.7
Erhardtsen, E.8
De Franchis, R.9
-
24
-
-
19044372377
-
To general haemostasis-the evidence-based route
-
E. Erhardtsen To general haemostasis-the evidence-based route Pathophysiol Haemost Thromb 32 2002 47 52
-
(2002)
Pathophysiol Haemost Thromb
, vol.32
, pp. 47-52
-
-
Erhardtsen, E.1
-
25
-
-
0344581058
-
Recombinant FVIIa in the management of uncontrolled hemorrhage
-
N.M. O'Connell, D.J. Perry, A.J. Hodgson, D.F. O'Shaughnessy, M.A. Laffan, and O.P. Smith Recombinant FVIIa in the management of uncontrolled hemorrhage Transfusion 43 2003 1711 1716
-
(2003)
Transfusion
, vol.43
, pp. 1711-1716
-
-
O'Connell, N.M.1
Perry, D.J.2
Hodgson, A.J.3
O'Shaughnessy, D.F.4
Laffan, M.A.5
Smith, O.P.6
|